Tell us more about what that looks like specifically.

We have as much time as you'd like.

Okay.

So, you know, the trial itself is a phase one trial.

It's FDA IDE.

And we, it's been sanctioned by the Baylor IRB, our data safety monitoring board.

It's got so many levels of protection and regulation because it's fetuses.

And tell us about how those fetuses, maybe babies, are doing.

Tell me about it and why it's such a worry for pregnant mothers.

Well, you know, it's a good point.

So gastroschisis is the most common congenital abdominal wall defect where what's happening in these babies is that their intestines, as you said, are outside of their body.

Now, what's interesting is that happens to everybody.

Your intestines were actually outside of your body when you were 10 weeks inside your mother, then hopefully they've gone back.

It looks like they've gone back.

It seems like they've gone back, but mostly it goes back.

So how did you even think, how do you even get the idea of operating on a baby in a womb? This seems like I'd never even heard of this.

Tell me about it and why it's such a worry for pregnant mothers.

Well, you know, it's a good point.

So gastroschisis is the most common congenital abdominal wall defect where what's happening in these babies is that their intestines, as you said, are outside of their body.

Now, what's interesting is that happens to everybody.

Your intestines were actually outside of your body when you were 10 weeks inside your mother.

Then hopefully they've gone back.

It looks like they've gone back.

So how did you even think, how do you even get the idea of operating on a baby in a womb? This seems like I'd never even heard of this.